HRAS1 (G12V) Protein

<strong>HRAS1 (G12V) Protein</strong>_x000D_ <strong>Catalog number:</strong> B2014729_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 84¬†kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> HRAS1 (G12V) Protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Neklesa TK, Tae HS, Schneekloth AR, Stulberg MJ, Corson TW, Sundberg TB, Raina K, Holley SA, Crews CM. Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins Nat Chem Biol. 2011 Jul 3;7(8):538-43._x000D_ 2: Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG. The HRAS1 minisatellite locus and risk of ovarian cancer Cancer Res. 2000 Jan 15;60(2):259-61._x000D_ 3: Zhang C, Lv GQ, Yu XM, Gu YL, Li JP, Du LF, Zhou P. Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis Breast Cancer Res Treat. 2011 Jul;128(2):467-72._x000D_ 4: Firgaira FA, Seshadri R, McEvoy CR, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Hopper JL. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years J Natl Cancer Inst. 1999 Dec 15;91(24):2107-11._x000D_ 5: Jazwinski SM, Kim S, Dai J, Li L, Bi X, Jiang JC, Arnold J, Batzer MA, Walker JA, Welsh DA, Lefante CM, Volaufova J, Myers L, Su LJ, Hausman DB, Miceli MV, Ravussin E, Poon LW, Cherry KE, Welsch MA; Georgia Centenarian Study and the Louisiana Healthy Aging Study. HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging Aging Cell. 2010 Oct;9(5):698-708._x000D_ 6: Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus Nat Genet. 1996 Mar;12(3):309-11._x000D_ 7: Zhang X, Jia M. Limited evidence supported the association of HRAS1 polymorphism with breast cancer risk Breast Cancer Res Treat. 2011 Jul;128(2):585-7._x000D_ 8: Vincent GM. Hypothesis for the molecular physiology of the Romano-Ward long QT syndrome J Am Coll Cardiol. 1992 Aug;20(2):500-3._x000D_ 9: Vousden KH, Bos JL, Marshall CJ, Phillips DH. Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination Proc Natl Acad Sci U S A. 1986 Mar;83(5):1222-6._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/1339391">10: Weitzel JN, Kasperczyk A, Mohan C, Krontiris TG. The HRAS1 gene cluster: two upstream regions recognizing transcripts and a third encoding a gene with a leucine zipper domain Genomics. 1992 Oct;14(2):309-19. </a>_x000D_ _x000D_ <strong>Products Related to HRAS1 (G12V) Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>